Combined administration of EGCG and curcumin (25 mg/kg & 200 mg/kg, respectively) in athymic female mice implanted with ERα-breast cancer cells showed reduced tumor volume with decreased VEGFR-1 expression [111]. The gene discussed is ESR1; the disease is breast cancer.